Catalyst Health Ventures (CHV) is a venture capital fund based in Newton, MA, that focuses on investing in innovative medical technologies. They specialize in therapeutic medical devices, diagnostics, and digital health solutions that have the potential to significantly improve patient outcomes and become the standard of care.
With a mission to address global unmet healthcare needs, CHV is dedicated to building a healthier future by supporting transformative MedTech solutions. Their portfolio includes companies like Sera Prognostics, which recently announced the success of their pivotal Prime Study, and their team is led by experienced founders and managing partners, Darshana Zaveri and Joshua S. Phillips.
Generated from the website